Translational Development Acquisition Corp. - Ordinary Shares (TDAC)

♥ 372 Thanks from members

Translational Development Acquisition Corp. (TDAC) demonstrates strong investor backing, evidenced by a successful shareholder vote and a low 15% redemption rate following its proposed business combination agreement with lithium ceramic battery leader ProLogium Holding Inc.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

Microchip Technology Incorporated (MCHP)

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)

NASDAQ

AbCellera Biologics Inc. - Common Shares (ABCL)

Entity & Market Metadata

Sector: Financial Services Industry: Blank Checks / SPAC Founder: Acquisition Sponsor Team Leadership: Management Team Holder: Institutional Investors Holder: Sponsor Founders Ordinary Shares #TDAC #Translational Development Acquisition #NASDAQ SPAC #Blank Check Company #IPO